carmustine has been researched along with Foreign-Body Reaction in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Foreign-Body Reaction: Chronic inflammation and granuloma formation around irritating foreign bodies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, MP | 1 |
| Tamada, JA | 1 |
| Brem, H | 1 |
| Langer, R | 1 |
1 other study available for carmustine and Foreign-Body Reaction
| Article | Year |
|---|---|
In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.
Topics: Animals; Biodegradation, Environmental; Brain Neoplasms; Carmustine; Cellulose, Oxidized; Decanoic A | 1994 |